Who owns Invesco Pharmaceuticals ETF?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of PJP from SEC Form 13F filings across 119 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 119 institutions disclosed 833,020 shares of Invesco Pharmaceuticals ETF worth $96.4M — about 28.7% of shares outstanding; the largest disclosed holder is Peak Asset Management, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
119
13F holders
$96.4M
value, 2026 filers
28.7%
of shares outstanding (833,020 sh)
21
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of PJP's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Peak Asset Management, LLC | 135,861 | $16.1M | 2.4% | 4.7% | +0.7% |
| 2 | MORGAN STANLEY | 102,176 | $12.1M | 0.0% | 3.5% | -61.9% |
| 3 | LPL Financial LLC | 50,062 | $5.9M | 0.0% | 1.7% | -36.7% |
| 4 | UBS Group AG | 42,970 | $5.1M | 0.0% | 1.5% | -1.6% |
| 5 | MML INVESTORS SERVICES, LLC | 39,043 | $4.6M | 0.0% | 1.3% | +41.8% |
| 6 | ENVESTNET ASSET MANAGEMENT INC | 36,897 | $4.4M | 0.0% | 1.3% | +35.9% |
| 7 | BANK OF AMERICA CORP /DE/ | 30,639 | $3.6M | 0.0% | 1.1% | -58.9% |
| 8 | WELLS FARGO & COMPANY/MN | 25,700 | $3.0M | 0.0% | 0.9% | -53.1% |
| 9 | RAYMOND JAMES FINANCIAL INC | 23,006 | $2.7M | 0.0% | 0.8% | -51.8% |
| 10 | Joseph Group Capital Management | 22,966 | $2.7M | 0.6% | 0.8% | +1.1% |
| 11 | DUMONT & BLAKE INVESTMENT ADVISORS LLC | 18,231 | $2.2M | 0.5% | 0.6% | +1.1% |
| 12 | Beacon Pointe Advisors, LLCNEW | 16,871 | $2.0M | 0.0% | 0.6% | new |
| 13 | ROYAL BANK OF CANADA | 16,832 | $2.0M | 0.0% | 0.6% | -73.0% |
| 14 | Trilogy Capital Inc. | 15,476 | $1.8M | 0.1% | 0.5% | -3.2% |
| 15 | Rockefeller Capital Management L.P. | 15,245 | $1.8M | 0.0% | 0.5% | +1136.4% |
| 16 | Institute for Wealth Management, LLC. | 12,101 | $1.4M | 0.1% | 0.4% | 0.0% |
| 17 | AMERIPRISE FINANCIAL INC | 11,596 | $1.4M | 0.0% | 0.4% | -41.4% |
| 18 | OSAIC HOLDINGS, INC. | 9,570 | $1.1M | 0.0% | 0.3% | +8.7% |
| 19 | Q3 Asset Management | 8,698 | $1,032 | 0.2% | 0.3% | +217.3% |
| 20 | Cetera Investment Advisers | 8,502 | $1.0M | 0.0% | 0.3% | -58.4% |
| 21 | COMMONWEALTH EQUITY SERVICES, LLC | 8,285 | $981,319 | 0.0% | 0.3% | -19.6% |
| 22 | WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 7,778 | $922,082 | 0.0% | 0.3% | +6.9% |
| 23 | Cambridge Investment Research Advisors, Inc. | 7,708 | $913 | 0.0% | 0.3% | -23.8% |
| 24 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 7,396 | $876,069 | 0.0% | 0.3% | +112.9% |
| 25 | STIFEL FINANCIAL CORP | 6,837 | $809,765 | 0.0% | 0.2% | +19.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.